Pulmonary Disease, Chronic Obstructive  >>  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
NCT00238082: The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease

Terminated
N/A
20
US
HFA-134A Beclomethasone DIpropionate (QVAR)
National Jewish Health
COPD
02/05
02/05
QvarCOPD, NCT01141452: Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD

Completed
N/A
815377
Europe
Extra-fine hydrofluoroalkane beclomethasone MDI, Qvar®, Chlorofluorocarbon beclomethasone metered dose inhaler, Fluticasone propionate metred dose inhaler, Hydrofluoroalkane beclomethasone metred dose inhaler, Chlorofluorocarbon beclomethasone dipropionate
Research in Real-Life Ltd, Teva Branded Pharmaceutical Products R&D, Inc.
Chronic Obstructive Pulmonary Disease
06/07
07/07

Download Options